title: Summary of a joint meeting between the Southwest Oncology Group and the Japanese clinical trials consortium.
authors.affiliation: Southwest Oncology Group, San Antonio, Texas 78245-3217.
authors.forename: M L
authors.initials: ML
authors.lastname: Rothenberg
authors.forename: C A
authors.initials: CA
authors.lastname: Coltman
authors.forename: M
authors.initials: M
authors.lastname: Fukushima
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000453:epidemiology; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007391:International Cooperation; D007564:Japan / Q000453:epidemiology; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000453:epidemiology; D008297:Male; D009369:Neoplasms / Q000188:drug therapy* / Q000453:epidemiology; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000453:epidemiology; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000453:epidemiology; D014481:United States / Q000453:epidemiology; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000453:epidemiology
chemical_list: D000970:Antineoplastic Agents